Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
O.V. Gaisenok*
Joint Hospital and Polyclinic, Department of Affairs of the President of Russian Federation. Michurinskiy prosp. 6, Moscow 119285, Russia
Current issues of atherothrombosis prevention and treatment optimization with antiplatelet therapy in patients with cardioascular diseases are discussed. Role of clopidogrel in contemporary antiplatelet therapy is focused on, especially in the aspect of the problem of aspirin resistance. Chronology of the clopidogrel generics appearance and prospects of their use is presented.
Key words: atherothrombosis, antiplatelet therapy, clopidogrel, generics.
Rational Pharmacother. Card. 2011;7(1):89-93
*Corresponding author: ovg.07@bk.ru